31 related articles for article (PubMed ID: 4056247)
1. Nonimmediate allergic reactions induced by Mesna.
Shimogori K; Araki M; Shibazaki S; Tuda K; Miura K
J Gen Fam Med; 2017 Oct; 18(5):285-287. PubMed ID: 29264044
[TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity reactions from antineoplastic agents.
Weiss RB; Baker JR
Cancer Metastasis Rev; 1987; 6(3):413-32. PubMed ID: 3319275
[TBL] [Abstract][Full Text] [Related]
3. Anaphylactoid reaction with bronchospasm following intravenous cyclophosphamide administration.
Salles G; Vial T; Archimbaud E
Ann Hematol; 1991; 62(2-3):74-5. PubMed ID: 2031970
[TBL] [Abstract][Full Text] [Related]
4. Quantification by gas chromatography of N,N'-di-(2-chloroethyl)-phosphorodiamidic acid in the plasma of patients receiving isophosphamide.
Bryant BM; Jarman M; Baker MH; Smith IE; Smyth JF
Cancer Res; 1980 Dec; 40(12):4734-8. PubMed ID: 7438105
[TBL] [Abstract][Full Text] [Related]
5. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.
Juma FD; Rogers HJ; Trounce JR
Br J Clin Pharmacol; 1980 Oct; 10(4):327-35. PubMed ID: 7448105
[No Abstract] [Full Text] [Related]
7. The effect of route of administration and fractionation of dose on the metabolism of ifosfamide.
Lind MJ; Roberts HL; Thatcher N; Idle JR
Cancer Chemother Pharmacol; 1990; 26(2):105-11. PubMed ID: 2347037
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity reaction to a metabolite of cyclophosphamide.
Kim HC; Kesarwala HH; Colvin M; Saidi P
J Allergy Clin Immunol; 1985 Oct; 76(4):591-4. PubMed ID: 4056247
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of oxazaphosphorines.
Sladek NE
Pharmacol Ther; 1988; 37(3):301-55. PubMed ID: 3290910
[No Abstract] [Full Text] [Related]
11. Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literature.
Papakonstantinou E; Müller S; Röhrbein JH; Wieczorek D; Kapp A; Jakob T; Wedi B
Contact Dermatitis; 2018 Apr; 78(4):274-280. PubMed ID: 29356000
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of resistance against cyclophosphamide and ifosfamide: can they be overcome without sacrificing selectivity?
Ludeman SM; Gamcsik MP
Cancer Treat Res; 2002; 112():177-97. PubMed ID: 12481717
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
